title: Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.
authors.forename: Michael
authors.initials: M
authors.lastname: Kulis
authors.forename: Katie
authors.initials: K
authors.lastname: Saba
authors.forename: Edwin H
authors.initials: EH
authors.lastname: Kim
authors.forename: J Andrew
authors.initials: JA
authors.lastname: Bird
authors.forename: Nikolas
authors.initials: N
authors.lastname: Kamilaris
authors.forename: Brian P
authors.initials: BP
authors.lastname: Vickery
authors.forename: Herman
authors.initials: H
authors.lastname: Staats
authors.forename: A Wesley
authors.initials: AW
authors.lastname: Burks
mesh_terms: D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology*; D010367:Arachis / Q000276:immunology*; D003888:Desensitization, Immunologic; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000097:blood / Q000378:metabolism*; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology; D021183:Peanut Hypersensitivity / Q000276:immunology* / Q000628:therapy*; D012463:Saliva / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D000485:Allergens; D007071:Immunoglobulin A, Secretory; D007073:Immunoglobulin E